Delivery Order SPE2DR25D1109-SPE2DR26FFK6K

The Defense Logistics Agency awarded a $2,916.35 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Epinephrine 0.3 mg auto-injector (2-pack units). This firm fixed-price contract, with an ultimate completion date of January 13, 2026, represents a routine pharmaceutical procurement executed through a competitive, non-set-aside process. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to military healthcare programs worldwide.

AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical and medical supply needs through open competition, with products spanning specialty medications, vaccines, generic and brand-name drugs, and medical devices across multiple therapeutic domains. This delivery order for epinephrine auto-injectors aligns with the company's established role as a primary pharmaceutical supplier to the Defense Logistics Agency and reflects the ongoing demand for critical emergency medical supplies within military healthcare infrastructure.